SPECTRUM OF HEPATOCELLULAR CARCINOMA AT SHIFA INTERNATIONAL HOSPITAL, ISLAMABAD
Abstract
Background: The aim of this study was to review etiological and clinical features of patients with hepatocellular carcinoma (HCC) at a tertiary care centre in past nine years. Relevant data on HCC in other parts of country and world were reviewed. Methods: Patients who had biopsy proven HCC were reviewed retrospectively. Demographic features were noted and positivity for serology, presence of cirrhosis, level of alpha-fetoprotein, tumour size and distribution of liver lesions were noted. Results: A total of 67 patients were found to have biopsy proven HCC. Mean age was 58.64 ± 12.77 years. Males were 79%. Hepatitis B surface antigen was noted to be positive in 23% of the patients, who were tested and hepatitis C antibody was found to be positive in 67% of the patients who were tested. Alpha fetoprotein level was 632.09 ± 1332.31. Cirrhosis was noted in 69% patients. Tumour size in patients with single lesion was 6.6 ± 1.14 cm. Patients with single lesion had 70% time involvement of the left lobe and 30% times had involvement of the right lobe. Fifty one percent of the patients in this series had multilocular distribution. Conclusion: Hepatocellular carcinoma has become a common tumour in Pakistan and studies are showing that this cancer is related to hepatitis C virus infection in majority of the patients. A large number of them have underlying cirrhosis and are multifocal in origin and are presented in an advanced condition.Key words: Hepatocellular carcinoma, Hepatitis C, Hepatitis B, Alpha fetoprotein, CirrhosisReferences
Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncol 2002; 62(Suppl): 8-17.
Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, et al. Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 2002; 99: 15584-9.
El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatol 2002; 36 (5 Suppl 1): S 74-83.
Ogunbiyi JO. Hepatocellular carcinoma in the developing world. Semin Oncol 2001;28:179-87.
Taseer JH, Malik IH, Mustafa G, Arshad M, Zafar MH, Shabbir I, et al. Association of primary hepatocellular carcinoma with hepatitis B virus. Bio Medica 1996; 12: 79-81.6. Malik IA, Ahmad N, Butt SA, Tariq WUZ, Muzaffar M, Bukhtiari N. The role of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in Northern Pakistan. J Coll Phy Surg Pak 1995; 5: 26-8.
Kausar S, Shafqat F, Shafi F, Khan AA. The association of hepatocellular carcinoma with hepatitis B and C viruses. Pak J Gastroenterol 1998; 12: 1-3.
Farooqi JI, Farooqi RJ. Relative frequency of hepatitis B and C viruses infections in cases of hepatocellular carcinoma in North West Frontier Province, Pakistan. J Coll Phy Surg Pak 2000; 10: 128-30.
Butt A, Khan A, Alam A, Ahmad S, Shah S, Shafqat F, et al. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc 1998; 48: 197-201.
Qureshi H, Zuberi SJ, Jafarey NA, Zaidi SH. Hepatocellular carcinoma in Karachi. J Gastroenterol Hepatol 1990; 5: 1-6.
Rehman AU, Murad S. Hepatocellular carcinoma: A retrospective analysis of 118 cases. J Coll Phy Surg Pak 2002; 12: 108-9.
Mumtaz MS, Iqbal R, Umar M, Khar B, Mumtaz MO, Anwar F, et al. Sero-prevalence of hepatitis B and C viruses in hepatocellular carcinoma. J Rawalpindi Med Coll 2001; 5: 78-80.
Chohan AR, Umar M, Khar B, Khurram m, Zahid M, Shah SF, et al. Demographic features of hepatocellular carcinoma: A study of 30 cases. J Rawalpindi Med Coll 2001; 5: 81-83.
Mujeeb SA, Jamal Q, Khanani R, Iqbal N, Kaher S. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan. Trop Doct 1997; 27: 45-6.
Omata M, Dan Y, Daniele B, Plentz R, Rudolph KL, Manna M, et al. Clinical features, etiology and survival of hepatocellular carcinoma among different countries. J Gastroenterol Hepatol 2002; 17 (Suppl) 540-9.
Shah GG, Qureshi IA, Hakim T, Tarin BA, Farooq MA, Qureshi PS. Radiological aspects of hepatocellular carcinoma: A hospital based study. Pak Armed Forces Med Jour 1999; 49: 54-7.
Del Olmo JA, Serra MA, Rodriguez F, Escudoro A, Gilabert S, Rodrigo JM. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol 1998; 124: 560-4.
Castells L, Vargas V, Gonzalez A, Esteban L, Esteba R, Guardia J. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 1995; 15: 159-63.
Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis Be antigen and risk of hepatocellular carcinoma. N Eng J Med 2002; 347: 168-74.
Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatol 2002; 36: 1206-13.
Parvez T, Anwar MS. Association of social class in HBsAg and hepatocellular carcinoma. J Coll Phy Surg Pak 2001; 11: 669-71.
Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, et al. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 1997; 35: 1059-67.
Sharieff S, Burney I, Salam A. Lack of correlation between alpha fetoprotein and tumor size in hepatocellular carcinoma. J Pak Med Assoc 2001;51: 123-4.
Khokhar N, Jadoon HA. Percutaneous liver biopsy using spinal needle. Pak J Gastroenterol 2002; 16: 9-11.
Yusuf NW, Jafri S, Masood G. The diagnostic role of targeted fine needle aspiration cytology of liver in malignant focal mass lesions–A cytohistological correlation. J Coll Phys Surg Pak 2000; 10: 109-12.
Khokhar N. Multi locular presentation of hepatocellular carcinoma. J Pak Med Assoc 2001; 51: 407-8.
Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, et al. Profile of hepatocellular carcinoma in India: An insight into possible etiologic associations. J Gastroenterol Hepatol 2001; 16: 666.
Hwang SJ, Tong MJ, Lai PP, Ko ES, CO RL, Chien D, et al. Evaluation of hepatitis B and C viral markers: Clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol 1996; 11: 949-54.
Wang BE, Ma WM, Sulaiman A, Noer S, Sumoharjo S, Sumarsidi D, et al. Demographic, clinical and virological characteristics of hepatocellular carcinoma is Asia: Survey of 414 patients from four countries. J Med Virol 2002; 67: 394-400.
Dick EA, Taylor-Robinson SD, Thomas HC, Gedoryc WM. Ablative therapy for liver tumors. Gut 2002;50:733-9.
Farooqi JI, Hameed K, Khan IU, Shah S. Efficacy of intrahepatic absolute alcohol in unresectable hepatocellular carcinoma. J Coll Phys Surg Pak 2001; 11: 383-6.
Farooqi JI, Farooqi RJ. Efficacy of Octreotide in cases of inoperable hepatocellular carcinoma: A clinical trial. J Coll Phys Surg Pak 2000; 10: 258-60.
Johnson PJ. Hepatocellular carcinoma: is current therapy really altering outcome? Gut 2002; 51: 459-62
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
